4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
ETHK Labs Inc. (1931) operates in the Medical Distribution industry and is headquartered in Shanghai, China with about 910 employees. Its market capitalization is roughly CNY 913 million. In the fiscal year ended 2025-12-31, 1931 reported CNY 2.8B in revenue and CNY 35M in net income.
ETHK Labs Inc., an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, After-sales Services, and Self-branded Products Business.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 2.8B | CNY 3.2B | CNY 3.1B | CNY 2.7B | — |
| Gross Profit | CNY 566M | CNY 751M | CNY 672M | CNY 608M | — |
| Operating Income (EBIT) | CNY 206M | CNY 462M | CNY 391M | CNY 361M | — |
| Net Income | CNY 35M | CNY 260M | CNY 238M | CNY 210M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (CNY 83M) | (CNY 141M) | (CNY 76M) | (CNY 53M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 5.9B | CNY 5.5B | CNY 4.8B | CNY 4.3B | — |
| Total Liabilities | CNY 2.9B | CNY 1.8B | CNY 1.4B | CNY 1.2B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1931 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms